Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders
75N98026R00007
The National Institute on Drug Abuse (NIDA) seeks a qualified organization to develop, manufacture, test, and distribute pharmaceutical drug products for its medications development program targeting substance use disorders. The contract will support the creation of dosage forms for both preclinical and clinical studies, involving both new chemical entities and previously approved drug substances.